Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Anna Kapusniak
Observed names:
A Kapuśniak,
A. Kapusniak,
A. Kapuśniak,
Anna Kapuśniak
Institution:
Creativ-Ceutical (France)
Observed institution:
Creativ-Ceutical (France)
OpenAlex ID:
A5009056524
Supply-side and demand-side policies for biosimilars: an overview in 10 European member states
2017
·
Cécile Rémuzat
, Anna Kapuśniak
, et al.
·
Journal of Market Access & Health Policy
·
70
Filling the gap in CNS drug development: evaluation of the role of drug repurposing
2017
·
A. Caban
, K. Pisarczyk
, et al.
·
Journal of Market Access & Health Policy
·
50
PDF
Vaccine market access pathways in the EU27 and the United Kingdom − analysis and recommendations for improvements
2021
·
Valérie Laigle
, Maarten J Postma
, et al.
·
Vaccine
·
25
PDF
Supply-Side and Demand-Side Policies for Biosimilars: An Overview in 10 European Member States
2016
·
C Rémuzat
, A Kapuśniak
, et al.
·
Value in Health
·
9
PBI7 Comparison of Biosimilar Policies between Key Countries in ASIA, EU and USA
2020
·
R. Skowron
, A. Kapusniak
, et al.
·
Value in Health Regional Issues
·
1
PDF
Public Health: The Forgotten Dimension of Health Technology Assessment
2026
·
Mondher Toumi
, Jaime Espin
, et al.
·
Journal of Evaluation in Clinical Practice
PDF
Completeness Before Certainty: Evidence Paradoxes in the First EU Joint Clinical Assessments
2026
·
Mondher Toumi
, Maarten Postma
, et al.
·
Preprints.org
Procedural Theatre: EU-HTA Between Ritual and Purpose—Why the Buyer’s Audit Has Outgrown the Transaction
2026
·
Mondher Toumi
, Maarten Jacobus Postma
, et al.
·
Journal of Market Access & Health Policy
Two Survival Cuts, One Silent Substitution: The Lurbinectedin Joint Clinical Assessment
2026
·
Mondher Toumi
, Samuel Aballéa
, et al.
·
Preprints.org
When Coordinators Legislate: The HTA Coordination Group’s Guiding Principles on Data Transparency and the Limits of Institutional Self-Empowerment
2026
·
Mondher Toumi
, Aurélie Mahalatchimy
, et al.
·
Preprints.org
HTA369 Who Speaks For Europe? A Country-Level Analysis Of Representation And Expertise In EU Health Technology Assessment Joint Bodies
2025
·
Roua ABBES
, Anna Kapusniak
, et al.
·
Value in Health
HTA114 Diverging Health Technology Assessment Outcomes Between SMC and HAS: A Focus on the Role of Indirect Treatment Comparisons
2025
·
Marta Wilk
, Malgorzata Wojtal
, et al.
·
Value in Health
HTA333 Market Access Challenges for Novel Therapies for Treatment of Severe Alopecia Areata
2024
·
M Wilk
, A Kapuśniak
, et al.
·
Value in Health
HPR2 The Use of Performance-Based Agreements in Common Diseases in EU3 and US
2024
·
M Wilk
, A Kapuśniak
, et al.
·
Value in Health
PDF
HPR124 Is Obesity a Disease or a Lifestyle Issue in Europe and the United States? Payer Perception
2024
·
I. Tyrała-Chowaniec
, A Kapuśniak
, et al.
·
Value in Health
PDF
PIN140 Drivers and Barriers to Vaccines Timely Access to Population in Europe: Perspectives from Experts Knowlegable of the Decision-Making Process
2020
·
A. Kapusniak
, C. Rémuzat
, et al.
·
Value in Health
PIN138 National and European Union-LEVEL Recommendations to Accelerate Vaccine Timely Access
2020
·
A. Kapusniak
, C. Rémuzat
, et al.
·
Value in Health
PIN36 Comparison of Vaccine Market Access Pathways in European and Asian Countries
2020
·
E. Tomaszek
, A. Kapusniak
, et al.
·
Value in Health Regional Issues
Pbi37 Biosimilar Interchangeability, Substitution and Switching: an Overview of 5 European Member States and the United States
2019
·
A. Zapała
, A. Kapuśniak
, et al.
·
Value in Health
Pin12 Market Access Pathways for Vaccines in Eu: the Need for More Transparent & Collaborative Framework in a Context of Eu28 to Decrease Uncertainty and Allow Faster Patient Access
2019
·
A. Kapuśniak
, C. Rémuzat
, et al.
·
Value in Health
Pin113 Eu Market Access Pathways for Vaccines: Definition of Country Archetypes Using Mathematical Clustering
2019
·
A. Kapusniak
, C. Rémuzat
, et al.
·
Value in Health
PDF
Php152 - Mechanisms of Illegal Export Causing Drugs Shortages in Poland
2018
·
A. Kapuśniak
, A. Caban
, et al.
·
Value in Health
Php63 - Measures to Fight Illegal Export Causing Drugs Shortages in Poland
2018
·
A. Kapuśniak
, A. Caban
, et al.
·
Value in Health
PDF
European Initiatives To Enhance Biosimilar Adoption
2017
·
A Kapuśniak
, C Rémuzat
, et al.
·
Value in Health
Drug Repurposing for Central Nervous System Disorders
2017
·
Mondher Toumi
, Aleksandra Caban
, et al.
·
CRC Press eBooks
Show more works
View as search
Works count:
27
Citation count:
155
H-index:
4
I10-index:
3
Year
Topic
Type